Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
6,761 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01002560 | The Identification of Novel Prognostic Markers in Melanoma | unknown | — | 500 | Royal Marsden NHS Foundation TrustOTHER | 1 | Oct 27, 2009 | clinicaltrials |
| NCT01000129 | Adaptive Planning in Bladder Cancer(APPLY) | unknown | Phase 2 | 32 | Royal Marsden NHS Foundation TrustOTHER | 1 | Oct 22, 2009 | clinicaltrials |
| NCT00090038 | Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma | completed | Phase 4 | 168 | BiogenINDUSTRY | 11 | Oct 20, 2009 | clinicaltrials |
| NCT00997464 | An Exploration of Genetic Testing for Prostate Cancer Susceptibility | unknown | — | 200 | Royal Marsden NHS Foundation TrustOTHER | 1 | Oct 19, 2009 | clinicaltrials |
| NCT00996255 | Dose-Escalation Study of PHA-793887 in Patients With Advanced/Metastatic Solid Tumors | terminated | Phase 1 | 19 | Nerviano Medical SciencesINDUSTRY | 2 | Oct 16, 2009 | clinicaltrials |
| NCT00220688 | Does Acupressure Help Reduce Nausea and Vomiting in Palliative Care Patients? | completed | N/A | 10 | Gloucestershire Hospitals NHS Foundation TrustOTHER | 1 | Oct 14, 2009 | clinicaltrials |
| NCT00143312 | Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell Transplants(VOSIFI) | completed | Phase 4 | 45 | PfizerINDUSTRY | 8 | Oct 6, 2009 | clinicaltrials |
| NCT00075218 | A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST) | completed | Phase 3 | 361 | PfizerINDUSTRY | 11 | Sep 28, 2009 | clinicaltrials |
| NCT00625768 | Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma | completed | Phase 1 | 13 | Antisoma ResearchINDUSTRY | 2 | Aug 25, 2009 | clinicaltrials |
| NCT00794859 | Sorafenib in Previously Treated Malignant Mesothelioma(SMS) | unknown | Phase 2 | 54 | King's College LondonOTHER | 1 | Aug 4, 2009 | clinicaltrials |
| NCT00253409 | Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery | unknown | N/A | 670 | Institute of Cancer Research, United KingdomOTHER | 1 | Jul 14, 2009 | clinicaltrials |
| NCT00345189 | Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors | completed | Phase 1 | 70 | BiogenINDUSTRY | 2 | Jul 14, 2009 | clinicaltrials |
| NCT00644319 | Ibuprofen or Morphine in Treating Pain in Patients Undergoing Pleurodesis for Malignant Pleural Effusion | unknown | Phase 2 | 320 | Oxford University Hospitals NHS TrustOTHER | 1 | Jul 8, 2009 | clinicaltrials |
| NCT00689845 | Combination Chemotherapy and Rituximab in Treating Patients With Primary Mediastinal Diffuse Large B-Cell Lymphoma | unknown | N/A | 120 | University Hospital Southampton NHS Foundation TrustOTHER | 1 | Jul 8, 2009 | clinicaltrials |
| NCT00899327 | Biomarkers in Patients at Risk of Developing Myelodysplastic Syndrome or Other Disorders and in Healthy Participants | unknown | — | 200 | Oxford University Hospitals NHS TrustOTHER | 1 | Jul 8, 2009 | clinicaltrials |
| NCT00498407 | A Phase II Study of CP-4055 as Second Line Therapy in Patients With Advanced Colorectal Cancer | completed | Phase 2 | 16 | Clavis PharmaINDUSTRY | 1 | Jun 4, 2009 | clinicaltrials |
| NCT00288925 | Z-360 in Unresectable Advanced Pancreatic Cancer in Combination With Gemcitabine Treatment | completed | Phase 1 / Phase 2 | 30 | Zeria PharmaceuticalINDUSTRY | 1 | Jun 1, 2009 | clinicaltrials |
| NCT00516802 | A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of PARP in Combination With Dacarbazine | completed | Phase 1 | 40 | AstraZenecaINDUSTRY | 2 | May 15, 2009 | clinicaltrials |
| NCT00497679 | AZD1152 in Patients With Advanced Solid Malignancies-Study 3 | terminated | Phase 1 | 45 | AstraZenecaINDUSTRY | 1 | May 14, 2009 | clinicaltrials |
| NCT00079248 | Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer | unknown | N/A | — | Institute of Cancer Research, United KingdomOTHER | 1 | May 12, 2009 | clinicaltrials |
| NCT00255463 | Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa Study | completed | Phase 2 | 185 | AstraZenecaINDUSTRY | 7 | Apr 23, 2009 | clinicaltrials |
| NCT00255476 | The IRESSA Novel Head and Neck Chemotherapy Evaluation Study | completed | Phase 2 | 64 | AstraZenecaINDUSTRY | 1 | Apr 23, 2009 | clinicaltrials |
| NCT00256711 | Phase II Iressa Versus Vinorelbine (INVITE) | completed | Phase 2 | 192 | AstraZenecaINDUSTRY | 10 | Apr 23, 2009 | clinicaltrials |
| NCT00275210 | MOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon Cancer | completed | Phase 3 | 2,246 | SanofiINDUSTRY | 19 | Apr 20, 2009 | clinicaltrials |
| NCT00234650 | Adenoma Detection Rate With Position Change at Colonoscopy | completed | N/A | 130 | London North West Healthcare NHS TrustOTHER | 1 | Apr 2, 2009 | clinicaltrials |
| NCT00294996 | Trial of Myocet in Metastatic Breast Cancer | unknown | Phase 3 | 363 | Sopherion TherapeuticsINDUSTRY | 11 | Mar 31, 2009 | clinicaltrials |
| NCT00098085 | Study of the Feasibility to Derive Vaccine From Tumor Tissue in Patients With Non-Small Cell Lung Cancer | completed | Phase 2 | 20 | Agenus Inc.INDUSTRY | 1 | Mar 9, 2009 | clinicaltrials |
| NCT00024375 | DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic Cancer | unknown | Phase 2 | — | TheradexINDUSTRY | 4 | Feb 18, 2009 | clinicaltrials |
| NCT00003016 | Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer | unknown | Phase 3 | 20,000 | University of OxfordOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00005052 | Vaccine Therapy in Treating Patients With Primary Stage II Melanoma | unknown | Phase 3 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 18 | Feb 9, 2009 | clinicaltrials |
| NCT00033683 | Combination Chemotherapy in Treating Women With Resected Breast Cancer | unknown | Phase 2 | — | Institute of Cancer Research, United KingdomOTHER | 2 | Feb 9, 2009 | clinicaltrials |
| NCT00077168 | Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole | unknown | Phase 2 | 2,000 | Institute of Cancer Research, United KingdomOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00837980 | Functional Imaging in HNC Undergoing Chemoradiation | unknown | — | 10 | Royal Marsden NHS Foundation TrustOTHER | 1 | Feb 6, 2009 | clinicaltrials |
| NCT00503412 | Phase I Orally Administered 14C-AZD2171 in Patients With Solid Metastatic Tumors | completed | Phase 1 | 6 | AstraZenecaINDUSTRY | 1 | Jan 19, 2009 | clinicaltrials |
| NCT00090025 | XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors | terminated | Phase 3 | 248 | Helsinn Healthcare SAINDUSTRY | 11 | Jan 14, 2009 | clinicaltrials |
| NCT00633269 | Study Assessing Metabolism, Excretion and Pharmacokinetics of a Poly (ADP-Ribose) Polymerase (PARP) Inhibitor in Patients With Solid Metastatic Tumours | completed | Phase 1 | 6 | AstraZenecaINDUSTRY | 1 | Jan 14, 2009 | clinicaltrials |
| NCT00174863 | Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate Cancer(ODYSSEY) | completed | Phase 2 | 232 | SanofiINDUSTRY | 13 | Dec 23, 2008 | clinicaltrials |
| NCT00290953 | Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide(SESAME) | completed | Phase 2 / Phase 3 | 432 | SanofiINDUSTRY | 14 | Dec 23, 2008 | clinicaltrials |
| NCT00127465 | Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their Confidants | completed | Phase 1 / Phase 2 | 400 | University of PlymouthOTHER | 1 | Dec 11, 2008 | clinicaltrials |
| NCT00089856 | GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer | terminated | Phase 3 | 626 | Cell GenesysINDUSTRY | 8 | Nov 5, 2008 | clinicaltrials |
| NCT00207103 | MAD in Cancer Patients: Safety of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | 68 | Bristol-Myers SquibbINDUSTRY | 4 | Nov 4, 2008 | clinicaltrials |
| NCT00432913 | Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa | completed | Phase 2 / Phase 3 | 120 | S.L.A. Pharma AGINDUSTRY | 2 | Oct 17, 2008 | clinicaltrials |
| NCT00169520 | SB-715992 In Combination With Docetaxel In Patients With Solid Tumors | completed | Phase 1 | 30 | GlaxoSmithKlineINDUSTRY | 1 | Oct 16, 2008 | clinicaltrials |
| NCT00555386 | Soy, Selenium and Breast Cancer Risk | completed | N/A | 27 | University of East AngliaOTHER | 1 | Sep 25, 2008 | clinicaltrials |
| NCT00133224 | Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients | terminated | Phase 3 | 408 | Cell GenesysINDUSTRY | 10 | Sep 23, 2008 | clinicaltrials |
| NCT00755651 | Studies on the H Pipelle, a New Device for Endometrial Sampling at Hysteroscopy | completed | N/A | 180 | Royal Free Hampstead NHS TrustOTHER | 1 | Sep 19, 2008 | clinicaltrials |
| NCT00749697 | Radioiodine Dosimetry Protocol for Thyroid Cancer Metastases | unknown | N/A | 10 | Royal Marsden NHS Foundation TrustOTHER | 1 | Sep 9, 2008 | clinicaltrials |
| NCT00747292 | Peri-Operative Management of Patients Undergoing Laparoscopic Colorectal Surgery | unknown | Phase 1 / Phase 2 | 99 | Minimal Access Therapy Training UnitOTHER | 1 | Sep 5, 2008 | clinicaltrials |
| NCT00235898 | Clinical Trial in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 300 | Mast Therapeutics, Inc.INDUSTRY | 5 | Aug 25, 2008 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials